Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

Health, Fitness & Food

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.)

Products You May Like

Articles You May Like

Here’s a rapid-fire update on what Trump will mean for all 33 portfolio stocks
I Tried the $7,500 a Month Gym. Is It Worth It?
Best Teas For Anxiety, According to an Expert
Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS
RFK Jr. is Trump’s pick to lead HHS — here’s what he could do with that power

Leave a Reply

Your email address will not be published. Required fields are marked *